Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rinaldo Zurbriggen

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Infection and Immunity|July 23, 2003
Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1Markus S Mueller, Annabelle Renard, Francesca Boato, et al.
Chembiochem : a European Journal of Chemical Biology|October 28, 2006
Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodium falciparum merozoite surface protein-1Sonya James, Kerstin Moehle, Annabelle Renard, et al.
Vaccine|September 17, 2005
Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitroReto Schumacher, Mario Amacker, Danielle Neuhaus, et al.
Human Vaccines|April 3, 2008
Preclinical profiling of the immunogenicity of a two-component subunit malaria vaccine candidate based on virosome technologyShinji L Okitsu, Markus S Mueller, Mario Amacker, et al.
Journal of Molecular Neuroscience : MN|September 28, 2005
Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's diseaseRinaldo Zurbriggen, Mario Amacker, Andreas R Kammer, et al.
Vaccine|June 30, 2009
Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cellsSophie Nallet, Mario Amacker, Nicole Westerfeld, et al.
Malaria Journal|January 1, 2010
Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccineMarco Tamborrini, Markus S Mueller, Sabine A Stoffel, et al.
Peptides|September 19, 2007
Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47 kDa fragment both in sporozoites and merozoitesShinji L Okitsu, Francesca Boato, Markus S Mueller, et al.
Plos One|October 11, 2007
A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteersBlaise Genton, Gerd Pluschke, Lukas Degen, et al.
Journal of Liposome Research|September 6, 2006
Advanced liposomal vectors as cancer vaccines in melanoma immunotherapyMichel Adamina, Reto Schumacher, Paul Zajac, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Infection and Immunity|July 23, 2003
Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1Markus S Mueller, Annabelle Renard, Francesca Boato, et al.
Chembiochem : a European Journal of Chemical Biology|October 28, 2006
Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodium falciparum merozoite surface protein-1Sonya James, Kerstin Moehle, Annabelle Renard, et al.
Vaccine|September 17, 2005
Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitroReto Schumacher, Mario Amacker, Danielle Neuhaus, et al.
Human Vaccines|April 3, 2008
Preclinical profiling of the immunogenicity of a two-component subunit malaria vaccine candidate based on virosome technologyShinji L Okitsu, Markus S Mueller, Mario Amacker, et al.
Journal of Molecular Neuroscience : MN|September 28, 2005
Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's diseaseRinaldo Zurbriggen, Mario Amacker, Andreas R Kammer, et al.
Vaccine|June 30, 2009
Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cellsSophie Nallet, Mario Amacker, Nicole Westerfeld, et al.
Malaria Journal|January 1, 2010
Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccineMarco Tamborrini, Markus S Mueller, Sabine A Stoffel, et al.
Peptides|September 19, 2007
Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47 kDa fragment both in sporozoites and merozoitesShinji L Okitsu, Francesca Boato, Markus S Mueller, et al.
Plos One|October 11, 2007
A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteersBlaise Genton, Gerd Pluschke, Lukas Degen, et al.
Journal of Liposome Research|September 6, 2006
Advanced liposomal vectors as cancer vaccines in melanoma immunotherapyMichel Adamina, Reto Schumacher, Paul Zajac, et al.
Pageof 4